AN2 Therapeutics, Inc. (ANTX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading ANTX…

AN2 Therapeutics, Inc. (ANTX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

AN2 Therapeutics, Inc.

ANTX · CIK 1880438

4 · Jan 7, 2026 · Prior Stephen David sold 6,462 shares at $1.01/share ($6,507)

4

Prior Stephen David sold 6,462 shares at $1.01/share ($6,507)

Filed: Jan 7, 2026
Period: Jan 5, 2026
Accession: 0001193125-26-006770
Filer: AN2 Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov